Qing Su
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Thyroid Disorders and Treatments
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 46
- Thyroid Disorders and Treatments 19
- Diabetes Treatment and Management 15
- Diabetes Management and Research 8
- Nephrology 21
- Chronic Kidney Disease and Diabetes 17
- Co-authors
- Hongmei Zhang (42 shared papers)Li Qin (37 shared papers)Kevin Rowley (7 shared papers)Yixin Niu (33 shared papers)ZHEN KUN YANG (27 shared papers)Zhijie Zhang (6 shared papers)Michael Ward (4 shared papers)Wei Tu (4 shared papers)
- Journals
- Journal of Diabetes (14 papers)Diabetes Care (10 papers)Frontiers in Endocrinology (9 papers)BMC Endocrine Disorders (6 papers)Cell Reports Medicine (5 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Qing Su
231 papers receiving 6k citations
Qing Su's Hit Papers
Peers
Comparison fields: 5 of 159
- Endocrinology, Diabetes and Metabolism 1.6k
- Nephrology 556
- Modeling and Simulation 279
- Epidemiology 661
- Nutrition and Dietetics 263
Countries citing papers authored by Qing Su
This map shows the geographic impact of Qing Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Su more than expected).
Fields of papers citing papers by Qing Su
This network shows the impact of papers produced by Qing Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Su. The network helps show where Qing Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Qing Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 238 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 398 | |
| 2 | 2012 | 302 | |
| 3 | 2012 | 192 | |
| 4 | 2019 | 173 | |
| 5 | Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis Hit paper breakdown → | 2022 | 170 |
| 6 | 2013 | 164 | |
| 7 | 2019 | 134 | |
| 8 | 2019 | 111 | |
| 9 | 2018 | 102 | |
| 10 | 2002 | 97 | |
| 11 | 2022 | 91 | |
| 12 | 2013 | 85 | |
| 13 | 2014 | 80 | |
| 14 | 2017 | 79 | |
| 15 | 2002 | 77 | |
| 16 | 2016 | 72 | |
| 17 | 2020 | 70 | |
| 18 | 2015 | 68 | |
| 19 | 2014 | 65 | |
| 20 | 2023 | 64 |
About Qing Su
Qing Su is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Epidemiology, Cardiology and Cardiovascular Medicine and Obstetrics and Gynecology, having authored 238 papers that have together received 6.2k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (46 papers), Liver Disease Diagnosis and Treatment (20 papers), Thyroid Disorders and Treatments (19 papers), Chronic Kidney Disease and Diabetes (17 papers), Diabetes Treatment and Management (15 papers), Cardiovascular Health and Risk Factors (9 papers), Diabetes Management and Research (8 papers) and Adipokines, Inflammation, and Metabolic Diseases (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Nephrology (556 citations), Modeling and Simulation (279 citations), Epidemiology (661 citations) and Nutrition and Dietetics (263 citations). Qing Su has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Hongmei Zhang, Li Qin, Kevin Rowley, Yixin Niu, ZHEN KUN YANG, Zhijie Zhang, Michael Ward, Wei Tu, Hongchao Qi and Kerin O’Dea. Their work appears in journals such as Journal of Diabetes, Diabetes Care, Frontiers in Endocrinology, BMC Endocrine Disorders and Cell Reports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.